Tubize Fin (Belgium) Performance
| TUB Stock | EUR 136.00 4.20 3.19% |
On a scale of 0 to 100, Tubize Fin holds a performance score of 10. The entity has a beta of 0.85, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tubize Fin's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tubize Fin is expected to be smaller as well. Please check Tubize Fin's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to make a quick decision on whether Tubize Fin's existing price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tubize Fin are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, Tubize Fin reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 983 K | |
| Total Cashflows From Investing Activities | 61.2 M | |
| Free Cash Flow | -1.2 M |
Tubize |
Tubize Fin Relative Risk vs. Return Landscape
If you would invest 11,680 in Tubize Fin on August 26, 2024 and sell it today you would earn a total of 1,920 from holding Tubize Fin or generate 16.44% return on investment over 90 days. Tubize Fin is generating 0.2476% of daily returns assuming 1.8309% volatility of returns over the 90 days investment horizon. Simply put, 16% of all stocks have less volatile historical return distribution than Tubize Fin, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Tubize Fin Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tubize Fin's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tubize Fin, and traders can use it to determine the average amount a Tubize Fin's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1352
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TUB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.83 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Tubize Fin is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tubize Fin by adding it to a well-diversified portfolio.
Tubize Fin Fundamentals Growth
Tubize Stock prices reflect investors' perceptions of the future prospects and financial health of Tubize Fin, and Tubize Fin fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tubize Stock performance.
| Return On Equity | 0.0988 | |||
| Return On Asset | -3.0E-4 | |||
| Current Valuation | 3.11 B | |||
| Shares Outstanding | 44.48 M | |||
| Price To Earning | 11.76 X | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 1,000,000 X | |||
| EBITDA | 380.25 M | |||
| Cash And Equivalents | 1.02 M | |||
| Cash Per Share | 0.02 X | |||
| Debt To Equity | 3.50 % | |||
| Book Value Per Share | 78.31 X | |||
| Cash Flow From Operations | (1.16 M) | |||
| Earnings Per Share | 7.19 X | |||
| Total Asset | 3.27 B | |||
| Retained Earnings | 1.67 B | |||
| Current Asset | 1000 K | |||
| Current Liabilities | 52 M | |||
About Tubize Fin Performance
Assessing Tubize Fin's fundamental ratios provides investors with valuable insights into Tubize Fin's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Tubize Fin is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Financire de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. The companys products in pipeline include UCB0942 for drug resistant epilepsy UCB3491 for infantile epilepsy UCB0599 for Parkinsons disease UCB7858UCB0159 for auto-inflammatory diseases UCB6673 to treat immunological diseases UCB4144VR942 to treat asthma seletalisib for treating Sjrgens syndrome dapirolizumab pegol for systemic lupus erythematosus bimekizumab to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis rozanolixizumab to treat immune thrombocytopenia and myasthenia gravis and romosozumab for post-menopausal osteoporosis and osteoporosis in men. TUBIZE FIN operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange.Things to note about Tubize Fin performance evaluation
Checking the ongoing alerts about Tubize Fin for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tubize Fin help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Tubize Fin until it has trouble settling it off, either with new capital or with free cash flow. So, Tubize Fin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Tubize Fin sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Tubize to invest in growth at high rates of return. When we think about Tubize Fin's use of debt, we should always consider it together with cash and equity. | |
| Tubize Fin has accumulated about 1.02 M in cash with (1.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 57.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Tubize Fin's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tubize Fin's stock is overvalued or undervalued compared to its peers.
- Examining Tubize Fin's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tubize Fin's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tubize Fin's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tubize Fin's stock. These opinions can provide insight into Tubize Fin's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Tubize Stock Analysis
When running Tubize Fin's price analysis, check to measure Tubize Fin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tubize Fin is operating at the current time. Most of Tubize Fin's value examination focuses on studying past and present price action to predict the probability of Tubize Fin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tubize Fin's price. Additionally, you may evaluate how the addition of Tubize Fin to your portfolios can decrease your overall portfolio volatility.